|
SCAPER expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.89849999999404E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.622280E-03 |
| Normal-vs-Stage2 |
1.959810E-03 |
| Normal-vs-Stage3 |
2.38399999999972E-05 |
| Normal-vs-Stage4 |
1.92248999999478E-05 |
| Stage1-vs-Stage2 |
4.485000E-01 |
| Stage1-vs-Stage3 |
9.541500E-02 |
| Stage1-vs-Stage4 |
8.788300E-02 |
| Stage2-vs-Stage3 |
6.722600E-01 |
| Stage2-vs-Stage4 |
4.635200E-01 |
| Stage3-vs-Stage4 |
6.757400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.2697000000036E-05 |
| Normal-vs-AfricanAmerican |
2.616000E-01 |
| Normal-vs-Asian |
1.914440E-02 |
| Caucasian-vs-AfricanAmerican |
9.319800E-02 |
| Caucasian-vs-Asian |
3.172800E-01 |
| AfricanAmerican-vs-Asian |
4.300400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.79889999954541E-07 |
| Normal-vs-Female |
9.983300E-04 |
| Male-vs-Female |
1.590280E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.956500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.154800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.59314999998994E-05 |
| Normal-vs-Age(81-100Yrs) |
1.659640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.995600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.701800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.235960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.349200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.990590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.869600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.102040E-01 |
| Classical-VS-Follicular |
2.009400E-01 |
| Classical-VS-Other |
4.692600E-01 |
| Classical-VS-Normal |
9.827900E-04 |
| Tall-VS-Follicular |
5.333600E-01 |
| Tall-VS-Other |
9.175600E-01 |
| Tall-VS-Normal |
1.206090E-04 |
| Follicular-VS-Other |
8.452400E-01 |
| Follicular-VS-Normal |
2.424300E-04 |
| Other-VS-Normal |
3.305700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.92750000000453E-05 |
| Normal-vs-N1 |
6.238900E-04 |
| N0-vs-N1 |
5.037000E-01 |
|
|
